(Q38564727)

4 September 2017

1 reference

title

Third International Congress on Epilepsy, Brain, and Mind: Part 2. (English)

1 reference

4 September 2017

16

1 reference

4 September 2017

19

1 reference

4 September 2017

22

1 reference

4 September 2017

14

0 references

Martin J Brodie

6

object named as

Martin J Brodie

0 references

Torbjörn Tomson

21

object named as

Torbjörn Tomson

1 reference

4 September 2017

7

Peter Brugger

1 reference

4 September 2017

Ivan Rektor

1

1 reference

4 September 2017

Steven C Schachter

2

1 reference

4 September 2017

Ravindra Arya

3

1 reference

4 September 2017

Shahar Arzy

4

1 reference

4 September 2017

Hilde Braakman

5

1 reference

4 September 2017

Martin J Brodie

6

1 reference

4 September 2017

Bernard S Chang

8

1 reference

4 September 2017

Alla Guekht

9

1 reference

4 September 2017

Bruce Hermann

10

1 reference

4 September 2017

Dale C Hesdorffer

11

1 reference

4 September 2017

Marilyn Jones-Gotman

12

1 reference

4 September 2017

Andres M Kanner

13

1 reference

4 September 2017

Pavel Mareš

15

1 reference

4 September 2017

Miri Neufeld

17

1 reference

4 September 2017

Gail L Risse

18

1 reference

4 September 2017

Margitta Seeck

20

1 reference

4 September 2017

publication date

8 August 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

50

1 reference

4 September 2017

page(s)

138-159

1 reference

Cognitive and behavioral complications of frontal lobe epilepsy in children: a review of the literature

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Cognitive and behavioural findings in children with frontal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Frontal lobe connectivity and cognitive impairment in pediatric frontal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Pediatric frontal lobe epilepsy: white matter abnormalities and cognitive impairment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Abnormal modular organization of functional networks in cognitively impaired children with frontal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy, cognition, and behavior: The clinical picture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Disentangling the relationship between epilepsy and its behavioral comorbidities - the need for prospective studies in new-onset epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Risk of recurrence after a first unprovoked seizure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy from the Patient's Perspective: Review of Results of a Community-Based Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Cognitive disorders associated with epilepsy: diagnosis and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Cognitive deficits and psychiatric disorders in patients with new-onset epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Children with new-onset epilepsy: neuropsychological status and brain structure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Cognitive progression in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Growing up with epilepsy: a two-year investigation of cognitive development in children with new onset epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Newly diagnosed epilepsy: cognitive outcome after 12 months.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Depression but not seizure factors or quality of life predicts suicidality in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The psychological impact of a newly diagnosed seizure: losing and restoring perceived control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Cognitive complaints after a first seizure in adulthood: Influence of psychological adjustment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epigenetic modulation of seizure-induced neurogenesis and cognitive decline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Dentate gyrus-specific knockdown of adult neurogenesis impairs spatial and object recognition memory in adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Enhancement of progenitor cell division in the dentate gyrus triggered by initial limbic seizures in rat models of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Functional implications of seizure-induced neurogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Fluoxetine targets early progenitor cells in the adult brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Immunohistological markers for staging neurogenesis in adult hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Regional expression of inducible heat shock protein-70 mRNA in the rat brain following administration of convulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by neuroprotective agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The effects of pentylenetetrazole-induced status epilepticus on behavior, emotional memory, and learning in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

A single pentylenetetrazole-induced clonic-tonic seizure episode is accompanied by a slowly developing cognitive decline in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Newly diagnosed epilepsy: cognitive outcome at 5 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Starting at the beginning: the neuropsychological status of children with new-onset epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy and brain inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Autoimmunity and inflammation in status epilepticus: from concepts to therapies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Role of inflammatory mediators in the pathogenesis of epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

A role for leukocyte-endothelial adhesion mechanisms in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The role of inflammation in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Inflammation in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Postoperative cognitive dysfunction: Involvement of neuroinflammation and neuronal functioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Effects of antiepileptic drugs on cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Certain secondary antiepileptic drugs can rescue hippocampal injury following a critical growth period despite poor anticonvulsant activity and cognitive deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Effects of repeated citalopram treatment on kainic acid-induced neurogenesis in adult mouse hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Repeated citalopram administration counteracts kainic acid-induced spreading of PSA-NCAM-immunoreactive cells and loss of reelin in the adult mouse hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Mechanisms of epileptogenesis and potential treatment targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Finding a better drug for epilepsy: antiinflammatory targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Consensus on diagnosis and management of JME: From founder's observations to current trends.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Management of juvenile myoclonic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Treatment options in juvenile myoclonic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Treating myoclonic epilepsy in children: state-of-the-art

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Valproic acid monotherapy in pregnancy and major congenital malformations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Valproate as monotherapy for juvenile myoclonic epilepsy: dose-effect study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Levetiracetam monotherapy--outcomes from an epilepsy clinic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Phenobarbital for the treatment of epilepsy in the 21st century: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Exacerbation of juvenile myoclonic epilepsy with lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Exacerbation of juvenile myoclonic epilepsy with lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Prognosis of juvenile myoclonic epilepsy is related to endophenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Antiepileptic drug combinations--have newer agents altered clinical outcomes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Clonazepam in juvenile myoclonic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Lifetime prognosis of juvenile myoclonic epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Unifying the definitions of sudden unexpected death in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Population-based study of the incidence of sudden unexplained death in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy and risk of death and sudden unexpected death in the young: a nationwide study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Long-term mortality in childhood-onset epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Sudden unexpected death in epilepsy: current knowledge and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Risk factors for sudden unexpected death in epilepsy: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Case-control study of SUDEP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Sudden unexpected death in epilepsy: a search for risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Combined analysis of risk factors for SUDEP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Serotonin receptors: guardians of stable breathing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Differences in serotonin receptor expression in the brainstem may explain the differential ability of a serotonin agonist to block seizure-induced sudden death in DBA/2 vs. DBA/1 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Prevention of seizure-induced sudden death in a chronic SUDEP model by semichronic administration of a selective serotonin reuptake inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Ictal hypoventilation contributes to cardiac arrhythmia and SUDEP: report on two deaths in video-EEG-monitored patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Chronic intermittent hypoxia elicits serotonin-dependent plasticity in the central neural control of breathing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Simulated apnoeas induce serotonin-dependent respiratory long-term facilitation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Central serotonin neurons are required for arousal to CO2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Transgenic mice lacking serotonin neurons have severe apnea and high mortality during development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Defects in breathing and thermoregulation in mice with near-complete absence of central serotonin neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The sudden infant death syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Multiple serotonergic brainstem abnormalities in sudden infant death syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Brainstem serotonergic deficiency in sudden infant death syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Abnormal serotonin receptor expression in DBA/2 mice associated with susceptibility to sudden death due to respiratory arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Sound-induced seizures in serotonin 5-HT2c receptor mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Oxygenation prevents sudden death in seizure-prone mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Prevention of sudden unexpected death in epilepsy: a realistic goal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Anticonvulsant effect of fluoxetine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The Use of Sertraline in Patients with Epilepsy: Is It Safe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Citalopram as treatment of depression in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Are morphologic and functional consequences of status epilepticus in infant rats progressive?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy and violence: medical and legal issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy in prisons: A diagnostic survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy in prison: elevated prevalence and no relationship to violence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Risk of violent crime in individuals with epilepsy and traumatic brain injury: a 35-year Swedish population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Aggression and violence in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Violence and postictal psychosis: A comparison of postictal psychosis, interictal psychosis, and postictal confusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Special report. The nature of aggression during epileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Frontal lobe epilepsy presented as ictal aggression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Directed aggressive behavior in frontal lobe epilepsy: a video-EEG and ictal spect case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Biting behavior, aggression, and seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Antiepileptic drug therapy: does mechanism of action matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Antiepileptics for aggression and associated impulsivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Psychiatric adverse events during levetiracetam therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Levetiracetam in refractory epilepsy: a prospective observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Discontinuation of levetiracetam because of behavioral side effects: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Behavioral effects of levetiracetam mitigated by pyridoxine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Topiramate and psychiatric adverse events in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

A prospective audit of adjunctive zonisamide in an everyday clinical setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The body in the brain revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Beyond re-membering: phantom sensations of congenitally absent limbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Supernumerary phantom limbs in spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Phantom limb after stroke: an underreported phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Studies in traumatic epilepsy. II. Focal motor and somatic sensory fits: a study of 85 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Supernumerary phantom limb as a rare symptom of epileptic seizures--case report and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Revealing the invisible: the paradox of picturing a phantom limb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Illusory Reduplication of One's Own Body: Phenomenology and Classification of Autoscopic Phenomena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Paroxysmal "feeling of somebody being nearby".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy, behavior, and art (Epilepsy, Brain, and Mind, part 1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Induction of an illusory shadow person

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Distinct illusory own-body perceptions caused by damage to posterior insula and extrastriate cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Heautoscopy, epilepsy, and suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Polyopic heautoscopy: Case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Autoscopic phenomena: case report and review of literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Unilateral autoscopic phenomena as a lateralizing sign in focal epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Semiologic value of ictal autoscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Ictal asomatognosia due to dominant superior parietal cortical dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Phantom sensations of internal organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Autoscopic phenomena with seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Out of the body, but not out of mind

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Full-body illusions and minimal phenomenal selfhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Stimulating illusory own-body perceptions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Linking out-of-body experience and self processing to mental own-body imagery at the temporoparietal junction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Abnormal self-location and vestibular vertigo in a patient with right frontal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Orientation and disorientation: lessons from patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Orientation failures in medicine and psychiatry: discussion paper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Space in the brain: how the hippocampal formation supports spatial cognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Hippocampal "time cells" bridge the gap in memory for discontiguous events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Differential influence of hippocampal subfields to memory formation: insights from patients with temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Memory, navigation and theta rhythm in the hippocampal-entorhinal system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The mental number line and the human angular gyrus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Spatial-temporal interactions in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The mental time line: an analogue of the mental number line in the mapping of life events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The human brain is intrinsically organized into dynamic, anticorrelated functional networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Extrinsic and intrinsic systems in the posterior cortex of the human brain revealed during natural sensory stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The 'intrinsic' system in the human cortex and self-projection: a data driven analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Reduplicative paramnesia: a disconnection syndrome of memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Capgras' syndrome of time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Self in time: imagined self-location influences neural activity related to mental time travel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Neural basis of embodiment: distinct contributions of temporoparietal junction and extrastriate body area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

"Gourmand syndrome": eating passion associated with right anterior lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Brain lesions and eating disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

"Gourmand syndrome" in a child with pharmacoresistant epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Prevalence and trends in obesity among US adults, 1999-2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Obesity in adults with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

A role for the right anterior temporal lobe in taste quality recognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

International physical activity questionnaire: 12-country reliability and validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Toward a neuroanatomy of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

A critical evaluation of obsessive-compulsive disorder subtypes: symptoms versus mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Obsessive-compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function, and anatomic correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Tourette syndrome, associated conditions and the complexities of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Obsessive–compulsive symptoms in patients with temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Obsessionality, obsessive–compulsive disorder, and temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Phenomenology of Obsessive Compulsive Disorder in Patients with Temporal Lobe Epilepsy or Tourette Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Hypergraphia in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The Interictal Behavior Syndrome of Temporal Lobe Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Temporal Lobe Epilepsy - A Syndrome Of Sensory-Limbic Hyperconnection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Quantitative analysis of interictal behavior in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Interictal behavior abnormality in temporal lobe epilepsy. A specific syndrome or nonspecific psychopathology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

7 January 2021

Personality in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Viscosity and social cohesion in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Frequency of hypergraphia in temporal lobe epilepsy: an index of interictal behaviour syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Hypergraphia in epilepsy: is there a specificity to temporal lobe epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

The neurological, psychosocial and demographic correlates of hypergraphia in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

7 January 2021

Epilepsy and verbosity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Association of temporal lobe epilepsy and obsessive-compulsive disorder in a patient successfully treated with right temporal lobectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Obsessive-compulsive disorder after epilepsy surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

New-onset obsessive-compulsive disorder following neurosurgery for medication-refractory seizure disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Epilepsy, suicidality, and psychiatric disorders: a bidirectional association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Signs of central nervous system dysfunction in obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

A comparative study of obsessive-compulsive disorder and other psychiatric comorbidities in patients with temporal lobe epilepsy and idiopathic generalized epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

Obsessive-compulsive symptoms in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

7 January 2021

The idea of a presence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.07.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2015.07.014

1 reference

4 September 2017

1 reference